Chord Energy heads into its Q1 2026 earnings report with a rare alignment: short sellers have been retreating, the analyst community is broadly constructive, and EPS momentum ranks near the top of the market — yet options traders suggest a touch more caution than usual.
The most striking shift in positioning has been the sharp reversal in short interest. From a local peak near 7% of the free float in late March, SI has fallen to 5.5% — a drop of roughly 22% over the past month — with the borrow lending market signalling little stress. Cost to borrow runs at just 0.41%, the lowest it has been in over a month, and availability in the lending pool remains wide. That combination points to short sellers who have been covering, not loading up. The ORTEX short score of 41 is moderate and has drifted lower over the past two weeks, consistent with easing rather than building pressure.
Options positioning is the one signal reading a degree warmer than usual. The put/call ratio climbed to 0.52 on Tuesday — about 1.3 standard deviations above its 20-day average of 0.43 — suggesting a modest uptick in downside hedging heading into the print. It is nowhere near extreme; the 52-week high on this metric is 2.62, and the stock's one-week gain of 6.4% to $149.16 tells its own story about directional sentiment.
The analyst debate centres squarely on whether Chord's Bakken-focused model can sustain the capital efficiency narrative that has driven a roughly 40% year-to-date outperformance against peers. Bulls point to an 18%-plus free cash flow yield projected for 2026, deep acreage inventory, and improved lateral drilling techniques. Bears flag slippage in oil production — output dipped from 155,700 to 153,000 barrels per day in Q4 2025 — and Bakken geology that carries more commodity-price sensitivity than core Permian peers. The consensus has moved firmly upward in recent weeks: Morgan Stanley upgraded to Overweight in late March, lifting its target from $114 to $168, while Wells Fargo and Truist both raised targets into the $170–$190 range. The mean target across the analyst base now sits at $165, roughly 11% above the current price. EPS momentum factor scores rank in the 95th–98th percentile for both the 30-day and 90-day windows, a level that implies the Street's numbers have been moving higher — not lower — into today's release.
Institutional ownership has been building in parallel. BlackRock added over 1 million shares in Q1 and Vanguard added 925,000, collectively bringing their combined stake close to 21% of shares outstanding. American Century nearly doubled its position in the latest reporting period, adding 630,000 shares. Against that backdrop, today's print will test whether Chord's Q1 production numbers and forward guidance on capital return — particularly the dividend yield and buyback cadence, priced at about 3.6% DPS/price — justify the valuation premium that has opened up versus close peers like MTDR and OVV, both of which gained more on the week but trade at wider discounts to net asset value.
See the live data behind this article on ORTEX.
Open CHRD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
